191 related articles for article (PubMed ID: 36450256)
1. Single-cell RNA sequencing identifies a paracrine interaction that may drive oncogenic notch signaling in human adenoid cystic carcinoma.
Parikh AS; Wizel A; Davis D; Lefranc-Torres A; Rodarte-Rascon AI; Miller LE; Emerick KS; Varvares MA; Deschler DG; Faquin WC; Aster JC; Lin DT; Bernstein BE; Drier Y; Puram SV
Cell Rep; 2022 Nov; 41(9):111743. PubMed ID: 36450256
[TBL] [Abstract][Full Text] [Related]
2. In-depth characterization of the salivary adenoid cystic carcinoma transcriptome with emphasis on dominant cell type.
Bell D; Bell AH; Bondaruk J; Hanna EY; Weber RS
Cancer; 2016 May; 122(10):1513-22. PubMed ID: 26953815
[TBL] [Abstract][Full Text] [Related]
3. An oncogenic MYB feedback loop drives alternate cell fates in adenoid cystic carcinoma.
Drier Y; Cotton MJ; Williamson KE; Gillespie SM; Ryan RJ; Kluk MJ; Carey CD; Rodig SJ; Sholl LM; Afrogheh AH; Faquin WC; Queimado L; Qi J; Wick MJ; El-Naggar AK; Bradner JE; Moskaluk CA; Aster JC; Knoechel B; Bernstein BE
Nat Genet; 2016 Mar; 48(3):265-72. PubMed ID: 26829750
[TBL] [Abstract][Full Text] [Related]
4. MYB RNA detection by in situ hybridisation has high sensitivity and specificity for the diagnosis of adenoid cystic carcinoma.
Tadi S; Cheung VK; Lee CS; Nguyen K; Luk PP; Low TH; Palme C; Clark J; Gupta R
Pathology; 2023 Jun; 55(4):456-465. PubMed ID: 37055331
[TBL] [Abstract][Full Text] [Related]
5. Proteogenomic Analysis of Salivary Adenoid Cystic Carcinomas Defines Molecular Subtypes and Identifies Therapeutic Targets.
Ferrarotto R; Mitani Y; McGrail DJ; Li K; Karpinets TV; Bell D; Frank SJ; Song X; Kupferman ME; Liu B; Lee JJ; Glisson BS; Zhang J; Aster JC; Lin SY; Futreal PA; Heymach JV; El-Naggar AK
Clin Cancer Res; 2021 Feb; 27(3):852-864. PubMed ID: 33172898
[TBL] [Abstract][Full Text] [Related]
6. Recurrent Fusions in MYB and MYBL1 Define a Common, Transcription Factor-Driven Oncogenic Pathway in Salivary Gland Adenoid Cystic Carcinoma.
Brayer KJ; Frerich CA; Kang H; Ness SA
Cancer Discov; 2016 Feb; 6(2):176-87. PubMed ID: 26631070
[TBL] [Abstract][Full Text] [Related]
7. Solid-type adenoid cystic carcinoma of the breast, a distinct molecular entity enriched in NOTCH and CREBBP mutations.
Massé J; Truntzer C; Boidot R; Khalifa E; Pérot G; Velasco V; Mayeur L; Billerey-Larmonier C; Blanchard L; Charitansky H; Soubeyran I; Iggo R; Arnould L; MacGrogan G
Mod Pathol; 2020 Jun; 33(6):1041-1055. PubMed ID: 31857685
[TBL] [Abstract][Full Text] [Related]
8. A subset of prostatic basal cell carcinomas harbor the MYB rearrangement of adenoid cystic carcinoma.
Bishop JA; Yonescu R; Epstein JI; Westra WH
Hum Pathol; 2015 Aug; 46(8):1204-8. PubMed ID: 26089205
[TBL] [Abstract][Full Text] [Related]
9. Assessment of p63 expression in the salivary gland neoplasms adenoid cystic carcinoma, polymorphous low-grade adenocarcinoma, and basal cell and canalicular adenomas.
Edwards PC; Bhuiya T; Kelsch RD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 May; 97(5):613-9. PubMed ID: 15153875
[TBL] [Abstract][Full Text] [Related]
10. A unifying gene signature for adenoid cystic cancer identifies parallel MYB-dependent and MYB-independent therapeutic targets.
Gao R; Cao C; Zhang M; Lopez MC; Yan Y; Chen Z; Mitani Y; Zhang L; Zajac-Kaye M; Liu B; Wu L; Renne R; Baker HV; El-Naggar A; Kaye FJ
Oncotarget; 2014 Dec; 5(24):12528-42. PubMed ID: 25587024
[TBL] [Abstract][Full Text] [Related]
11. MYB-activated models for testing therapeutic agents in adenoid cystic carcinoma.
Jiang Y; Gao R; Cao C; Forbes L; Li J; Freeberg S; Fredenburg KM; Justice JM; Silver NL; Wu L; Varma S; West R; Licht JD; Zajac-Kaye M; Kentsis A; Kaye FJ
Oral Oncol; 2019 Nov; 98():147-155. PubMed ID: 31606723
[TBL] [Abstract][Full Text] [Related]
12. Genetic hallmarks of recurrent/metastatic adenoid cystic carcinoma.
Ho AS; Ochoa A; Jayakumaran G; Zehir A; Valero Mayor C; Tepe J; Makarov V; Dalin MG; He J; Bailey M; Montesion M; Ross JS; Miller VA; Chan L; Ganly I; Dogan S; Katabi N; Tsipouras P; Ha P; Agrawal N; Solit DB; Futreal PA; El Naggar AK; Reis-Filho JS; Weigelt B; Ho AL; Schultz N; Chan TA; Morris LG
J Clin Invest; 2019 Oct; 129(10):4276-4289. PubMed ID: 31483290
[TBL] [Abstract][Full Text] [Related]
13. The Immune Landscape of Chinese Head and Neck Adenoid Cystic Carcinoma and Clinical Implication.
Dou S; Li R; He N; Zhang M; Jiang W; Ye L; Yang Y; Zhao G; Yang Y; Li J; Chen D; Zhu G
Front Immunol; 2021; 12():618367. PubMed ID: 34552580
[TBL] [Abstract][Full Text] [Related]
14. Whole exome sequencing of adenoid cystic carcinoma.
Stephens PJ; Davies HR; Mitani Y; Van Loo P; Shlien A; Tarpey PS; Papaemmanuil E; Cheverton A; Bignell GR; Butler AP; Gamble J; Gamble S; Hardy C; Hinton J; Jia M; Jayakumar A; Jones D; Latimer C; McLaren S; McBride DJ; Menzies A; Mudie L; Maddison M; Raine K; Nik-Zainal S; O'Meara S; Teague JW; Varela I; Wedge DC; Whitmore I; Lippman SM; McDermott U; Stratton MR; Campbell PJ; El-Naggar AK; Futreal PA
J Clin Invest; 2013 Jul; 123(7):2965-8. PubMed ID: 23778141
[TBL] [Abstract][Full Text] [Related]
15. Mutation signature of adenoid cystic carcinoma: evidence for transcriptional and epigenetic reprogramming.
Frierson HF; Moskaluk CA
J Clin Invest; 2013 Jul; 123(7):2783-5. PubMed ID: 23778135
[TBL] [Abstract][Full Text] [Related]
16. Diffuse Staining for Activated NOTCH1 Correlates With NOTCH1 Mutation Status and Is Associated With Worse Outcome in Adenoid Cystic Carcinoma.
Sajed DP; Faquin WC; Carey C; Severson EA; H Afrogheh A; A Johnson C; Blacklow SC; Chau NG; Lin DT; Krane JF; Jo VY; Garcia JJ; Sholl LM; Aster JC
Am J Surg Pathol; 2017 Nov; 41(11):1473-1482. PubMed ID: 28914715
[TBL] [Abstract][Full Text] [Related]
17. Targeting the Oncogenic Transcriptional Regulator MYB in Adenoid Cystic Carcinoma by Inhibition of IGF1R/AKT Signaling.
Andersson MK; Afshari MK; Andrén Y; Wick MJ; Stenman G
J Natl Cancer Inst; 2017 Sep; 109(9):. PubMed ID: 28954282
[TBL] [Abstract][Full Text] [Related]
18. MYB alternative promoter activity is increased in adenoid cystic carcinoma metastases and is associated with a specific gene expression signature.
Huang J; Fehr A; Jäwert F; Nilsson JA; Morris LGT; Stenman G; Andersson MK
Oral Oncol; 2024 Apr; 151():106763. PubMed ID: 38493544
[TBL] [Abstract][Full Text] [Related]
19. Single-cell RNA sequencing reveals the heterogeneity and microenvironment in one adenoid cystic carcinoma sample.
An PG; Wu WJ; Tang YF; Zhang J
Funct Integr Genomics; 2023 May; 23(2):155. PubMed ID: 37162576
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic implications of Myb and Beta-catenin expression in adenoid cystic carcinoma.
Park S; Vora M; van Zante A; Humtsoe J; Kim HS; Yom S; Agarwal S; Ha P
J Otolaryngol Head Neck Surg; 2020 Jul; 49(1):48. PubMed ID: 32650834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
